The DLC test measures the levels of free light chains in the blood, specifically kappa and lambda light chains. These are components of immunoglobulins, and their levels can be useful in diagnosing and monitoring conditions like multiple myeloma and other plasma cell disorders.

Pre-Test Risks: There are generally no specific risks associated with the blood draw itself, but if you have a bleeding disorder or are on anticoagulant therapy, this should be communicated to your healthcare provider.
Post-Test Risks: Interpretation of results should be performed by a healthcare provider, as abnormalities may require further diagnostic workup or clinical correlation.

Kappa Light Chains: Typically, the normal range is approximately 3.3 to 19.4 mg/L.
Lambda Light Chains: Typically, the normal range is approximately 5.7 to 26.3 mg/L.

These ranges can vary slightly depending on the laboratory and the specific assay used.

Elevated Kappa or Lambda Light Chains: Increased levels can indicate plasma cell disorders, such as multiple myeloma or light chain amyloidosis.
Elevated Kappa/Lambda Ratio: An abnormal ratio (either too high or too low) can suggest a monoclonal gammopathy, which could be associated with malignancies or other conditions.
Low Light Chain Levels: This can occur in conditions like heavy chain diseases or in the setting of renal dysfunction.

The test requires a blood sample, typically obtained via venipuncture. The sample is usually collected in a serum separator tube or a tube containing EDTA for plasma.